Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Angew Chem Int Ed Engl ; 51(50): 12477-81, 2012 Dec 07.
Artigo em Inglês | MEDLINE | ID: mdl-23065749

RESUMO

Working together to uncover the truth: A molecule-sized diagnostic system combining several recognition elements and four fluorescence-emission channels enabled the identification of a wide range of pharmaceuticals on the basis of distinct photophysical processes. The molecular sensor (see simplified representation; ID = identification) was also used to analyze drug concentrations and combinations in urine samples in a high-throughput manner.


Assuntos
Transferência Ressonante de Energia de Fluorescência , Preparações Farmacêuticas/análise , Antibacterianos/análise , Antibacterianos/urina , Transporte de Elétrons , Corantes Fluorescentes/química , Humanos , Conformação Molecular , Preparações Farmacêuticas/urina , Sistemas Automatizados de Assistência Junto ao Leito , Análise de Componente Principal
2.
FASEB J ; 26(11): 4628-36, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22872679

RESUMO

Understanding the structural organization of lipids in the cell and viral membranes is essential for elucidating mechanisms of viral fusion that lead to entry of enveloped viruses into their host cells. The HIV lipidome shows a remarkable enrichment in dihydrosphingomyelin, an unusual sphingolipid formed by a dihydrosphingosine backbone. Here we investigated the ability of dihydrosphingosine to incorporate into the site of membrane fusion mediated by the HIV envelope (Env) protein. Dihydrosphingosine as well as cholesterol, fatty acid, and tocopherol was conjugated to highly conserved, short HIV-1 Env-derived peptides with no antiviral activity otherwise. We showed that dihydrosphingosine exclusively endowed nanomolar antiviral activity to the peptides (IC(50) as low as 120 nM) in HIV-1 infection on TZM-bl cells and on Jurkat T cells, as well as in the cell-cell fusion assay. These sphingopeptides were active against enfuvirtide-resistant and wild-type CXCR4 and CCR5 tropic HIV strains. The anti-HIV activity was determined by both the peptides and their dihydrosphingosine conjugate. Moreover, their mode of action involved accumulation in the cells and viruses and binding to membranes enriched in sphingomyelin and cholesterol. The data suggest that sphingopeptides are recruited to the HIV membrane fusion site and provide a general concept in developing inhibitors of sphingolipid-mediated biological systems.


Assuntos
Farmacorresistência Viral , Proteína gp41 do Envelope de HIV/farmacologia , Inibidores da Fusão de HIV/farmacologia , HIV-1/efeitos dos fármacos , Fragmentos de Peptídeos/farmacologia , Esfingosina/análogos & derivados , Fusão Celular , Linhagem Celular , Colesterol/química , Enfuvirtida , Proteína gp41 do Envelope de HIV/química , Proteína gp41 do Envelope de HIV/genética , Proteína gp41 do Envelope de HIV/metabolismo , Humanos , Modelos Moleculares , Estrutura Molecular , Plasma/metabolismo , Conformação Proteica , Proteínas Recombinantes/química , Proteínas Recombinantes/farmacologia , Esfingomielinas , Esfingosina/química , Esfingosina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...